recent
public
complet
genom
sequenc
leishmania
major
trypanosoma
brucei
trypanosoma
cruzi
reveal
genom
contain
proteincod
gene
common
three
genom
usher
new
postgenom
era
trypanosomatid
drug
discoveri
vast
amount
new
inform
make
possibl
comprehens
accur
target
identif
use
sever
new
comput
approach
includ
identif
metabol
chokepoint
search
parasit
proteom
orthologu
known
drug
target
identif
parasit
protein
like
interact
known
drug
druglik
small
molecul
chapter
describ
sever
databas
genedb
brenda
kegg
metacyc
thempeut
target
databas
chembank
algorithm
includ
patholog
pathway
hunter
tool
develop
facilit
bioinformat
analys
underli
approach
target
identif
first
step
drug
develop
pipelin
new
approach
give
rise
renew
optim
discoveri
new
drug
combat
devast
diseas
caus
parasit
tradit
drug
discoveri
trypanosomatid
organ
proceed
two
differ
start
point
screen
larg
number
exist
compound
activ
whole
parasit
focus
screen
compound
activ
defin
molecular
target
exist
antitrypanosomatid
drug
develop
use
former
approach
although
latter
gain
much
attent
last
twenti
year
rubric
ration
drug
design
recent
one
major
bottleneck
antitrypanosomatid
drug
develop
abil
identifi
good
target
sinc
small
percentag
total
number
trypanosomatid
gene
known
chang
forev
recent
juli
public
tritryp
trypanosoma
brucei
trypanosoma
cruzi
leishmania
major
genom
sequenc
tm
vast
amount
inform
make
possibl
sever
new
approach
target
identif
usher
postgenom
era
trypanosomatid
drug
discoveri
small
sequenc
insert
rel
trypanosom
lower
gene
densiti
leishmania
mostli
explain
larger
intercd
region
speci
contain
number
gene
famili
vari
size
predict
function
ascrib
proteincod
gene
confirm
experiment
protein
remain
gene
encod
conserv
hypothet
protein
slightli
half
found
trypanosomatid
interestingli
tritryp
protein
relat
found
prokaryot
eukaryot
least
appear
arisen
horizont
gene
transfer
may
repres
excel
candid
drug
target
tritryp
genom
display
remark
degre
synteni
gene
l
major
orthologu
speci
occur
genom
context
see
tabl
protein
within
tritryp
core
proteom
exhibit
averag
ident
brucei
cruzi
ident
l
major
two
trypanosom
reflect
expect
phylogenet
relationship
interestingli
substanti
fewer
orthologu
share
l
major
brucei
l
major
cruzi
perhap
reflect
common
intracellular
environ
mammalian
stage
howev
three
genom
contain
signific
number
speciesspecif
gene
account
proteincod
gene
brucei
cruzi
respect
l
major
gene
speciesspeciflc
gene
pseudogen
mostli
encod
larg
famili
surfac
protein
exemplifi
variant
surfac
glycoprotein
vsg
procycl
acid
repetit
protein
epparpprocyclin
brucei
transsialidas
dispers
gene
famili
protein
mucin
mucinassoci
surfac
protein
masp
cruzi
amastin
andpromastigot
surfac
antigen
l
major
addit
speciesspeciflc
gene
three
speci
demonstr
differenti
paralog
gene
expans
contract
adenylateguanyl
cyclas
leucinerich
repeat
protein
overrepres
brucei
surfac
proteas
recombin
hot
spot
rh
protein
cruzi
mitochondri
carrier
protein
atpbind
cassett
abc
transport
heat
shock
protein
hsp
gene
famili
l
major
mani
speciesspeciflc
gene
paralog
expans
occur
telomer
subtelomer
gene
duster
possibl
reflect
similar
strategi
use
immun
evas
transcript
rna
process
trypanosomatid
quit
differ
eukaryot
uniqu
unusu
process
larg
polycistron
gene
duster
rna
polymeras
imedi
transcript
proteincod
gene
transsplic
annot
tritryp
genom
uncov
expect
rnap
polymeras
subunit
dearth
transcript
factor
normal
involv
regul
transcript
initi
eukaryot
howev
recent
experi
identifi
sever
highli
diverg
transcript
factor
brucei
suggest
tritryp
transcript
initi
may
repres
ancestr
less
sequencespecif
mechan
mosdi
replac
eukaryot
archetyp
tatacontain
promot
convers
pauciti
tritryp
gene
encod
transcript
regul
offset
abund
protein
rna
bind
motif
consist
relianc
posttranscript
model
gene
regul
dna
replic
trypanosomatid
also
appear
differ
significandi
higher
eukaryot
one
six
subunit
typic
found
eukaryot
replic
origin
complex
identifi
also
substanti
differ
mitochondri
replic
machineri
sinc
complex
kinetoplast
dna
trypanosomatid
lent
mitochondri
genom
structur
dictat
unusu
replic
mechan
bioinformat
analys
tritryp
genom
suggest
lack
sever
class
signal
molecul
found
eukaryot
includ
serpentin
receptor
heterotrimer
g
protein
class
catalyt
receptor
interact
domain
regulatori
transcript
factor
possess
larg
complex
set
protein
kinas
protein
phosphatas
howev
distribut
protein
kinas
class
differ
organ
tyrosin
kinas
dual
specif
kinas
receptor
kinas
tkl
rgc
group
kinas
sinc
trypanosomatid
complic
life
cycl
differ
host
like
kinas
play
import
role
regul
respons
chang
differ
environ
experi
gain
pharmaceut
industri
last
decad
drug
develop
lead
postul
number
select
criteria
success
drug
target
identif
context
trypanosomatid
criteria
includ
select
ie
parasit
target
absent
substanti
differ
host
druggabl
target
structur
small
moleculebind
pocket
suitabl
biochem
properti
target
low
turnov
rate
andor
catalyz
ratelimit
step
within
pathway
valid
target
essenti
growth
andor
surviv
mammalian
stage
parasit
lifecycl
assay
specif
inexpens
highthroughput
screen
avail
use
vitro
express
target
low
potenti
develop
drug
resist
absenc
differ
isoform
allel
andor
biochem
bypass
reaction
criteria
mind
sever
bioinformat
approach
propos
take
advantag
avail
complet
genom
sequenc
describ
acceler
progress
develop
effect
clinic
intervent
import
diseas
caus
parasit
analysi
tritryp
genom
provid
comprehens
view
parasit
metabol
potenti
identifi
numer
common
speciesspecif
metabol
transport
process
manual
examin
metabol
map
identifi
number
pathway
appear
especi
amen
potenti
chemotherapeut
intervent
includ
glycolysi
electron
transport
chain
urea
cycl
glyoxylas
pathway
associ
trypanothion
metabol
glycosylphosphatidylinositol
gpi
anchor
biosynthesi
fatti
acid
biosynthesi
well
ergosterol
isoprenoid
biosynthet
pathway
sinc
particular
target
identif
drug
develop
pathway
other
describ
detail
sever
accompani
chapter
elsewher
explor
instead
sever
differ
comput
attempt
catalogu
metabol
pathway
identifi
chokepoint
describ
brenda
braunschweig
enzym
databas
comprehens
collect
enzym
metabol
inform
http
wwwbrendaunikoelnd
includ
enzym
commiss
ec
classif
nomenclatur
reaction
specif
function
structur
isol
stabil
well
link
primari
literatur
refer
databas
base
control
vocabulari
ontolog
inform
field
search
tool
includ
ec
taxonomytre
browser
chemic
substructur
search
engin
ligand
structur
thesauru
ligand
name
brenda
contain
enzym
repres
differ
ec
number
differ
organ
current
septemb
entri
brucei
cruzi
l
major
kegg
kyoto
encyclopedia
gene
genom
suit
databas
associ
softwar
design
integr
current
knowledg
gene
protein
gene
databas
chemic
compound
reaction
ligand
metabol
regulatori
interact
network
pathway
ontolog
bri
biolog
system
repres
kegg
nest
graph
use
pathway
reconstruct
function
infer
line
graph
form
basi
integr
genom
chemic
inform
network
brute
databas
provid
pathway
reconstruct
seri
function
hierarchi
repres
logic
foundat
kegg
project
kegg
maintain
gene
catalogu
map
onto
manual
drawn
curat
refer
pathway
currendi
entri
pathway
databas
brucei
cruzi
l
major
respect
mostli
describ
metabol
pathway
biocyc
collect
pathwaygenom
databas
pgdb
provid
electron
refer
sourc
pathway
genom
differ
organ
http
biocycorg
databas
within
biocyc
collect
organ
tier
accord
amount
manual
review
updat
receiv
tier
pgdb
creat
intens
manual
effort
receiv
continu
updat
ecocyc
describ
escherichia
coli
organismspecif
tier
databas
tier
pgdb
comput
gener
use
patholog
softwar
undergon
moder
amount
review
updat
current
databas
tier
includ
humancyc
piasmocyc
describ
malaria
parasit
plasmodium
falciparum
tier
databas
comput
gener
patholog
program
undergon
review
updat
pgdb
tier
repres
mostli
bacteri
genom
individu
biocyc
websit
use
visual
singl
multipl
metabol
pathway
includ
complet
metabol
map
organ
omic
viewer
use
analyz
gene
express
proteom
metabolom
data
produc
anim
view
timecours
geneexpress
experi
current
biocyc
pgdb
trypanosomatid
genom
although
rel
straightforward
gener
tier
databas
use
patholog
softwar
program
also
avail
genomescal
reconstruct
metabol
network
howev
sinc
process
larg
depend
sequencebas
homolog
search
identifi
enzym
tritryp
genom
quit
diverg
eukaryot
consider
manual
curat
probabl
necessari
obtain
truli
accur
represent
metabol
network
organ
individu
pgdb
within
biocyc
repres
speciesspecif
databas
metacyc
http
metacycorg
collect
metabol
pathway
enzym
organ
mostli
bacteria
plant
goal
metacyc
repres
everi
experiment
elucid
metabol
pathway
reaction
chemic
compound
well
gene
encod
enzym
catalyz
reaction
involv
well
use
refer
sourc
look
individu
fact
metacyc
facilit
comput
studi
metabol
design
novel
biochem
pathway
biotechnolog
studi
evolut
metabol
pathway
simul
metabol
pathway
addit
desktop
softwar
avail
compar
overal
metabol
map
specif
pathway
genom
map
two
organ
care
manual
examin
metabol
pathway
identifi
metabol
chokepoint
ie
enzym
uniqu
necessari
produc
critic
metabolit
obvious
chokepoint
pathway
result
metabolit
critic
parasit
surviv
would
make
excel
potenti
target
develop
novel
antitrypanosomatid
drug
pathway
hunter
tool
http
wwwphtunikoelnd
use
extend
form
graph
theori
enzym
repres
edg
node
repres
metabolit
identifi
chokepoint
rank
accord
load
load
defin
ratio
number
shortest
path
enzym
nearest
neighbor
attach
compar
averag
valu
properti
entir
network
comparison
pathogen
trypanosomatid
host
human
metabol
network
could
use
identifi
highli
rank
chokepoint
uniqu
parasit
rank
much
lower
host
anoth
comput
approach
identif
metabol
enzym
drug
target
involv
concept
minim
cut
set
defin
minim
set
reaction
network
whose
inactiv
definit
lead
failur
particular
network
fimction
screen
parasit
metabol
network
possibl
minim
cut
set
identif
small
ie
contain
enzym
present
host
could
serv
identifi
potenti
drug
target
approach
oudin
design
identifi
target
meet
criteria
outlin
begin
section
name
suitabl
biochem
properti
like
essenti
parasit
suffici
differ
host
homologu
howev
altern
approach
seek
make
use
find
success
drug
specif
structur
physicochem
properti
allow
efficaci
bioavail
safe
properti
exemplifi
lipinski
socal
rule
five
lead
concept
druggabl
protein
base
abil
bind
potenti
effect
druglik
small
molecul
thu
make
sens
search
tritryp
genom
protein
like
meet
criteria
two
differ
approach
propos
develop
comput
solut
problem
search
genom
protein
similar
properti
known
drug
target
organ
primarili
human
direct
interrog
parasit
protein
likelihood
bind
druglik
chemic
therapeut
target
databas
ttd
http
repres
comprehens
publicli
avail
attempt
catalogu
inform
current
known
protein
nucleic
acid
target
describ
literatur
databas
also
contain
inform
drug
ligand
direct
target
well
correspond
diseas
condit
databas
current
contain
target
drug
ligand
includ
entri
list
potenti
antitrypanosomatid
use
simplist
approach
search
tritryp
genom
potenti
target
similar
exist
target
would
carri
blastp
psiblast
search
tritryp
protein
databas
identifi
parasit
protein
signific
sequenc
similar
ttd
result
list
parasit
protein
would
need
subsequ
winnow
remov
similar
human
orthologu
andor
similar
protein
involv
two
pathway
human
sinc
drug
like
deleteri
effect
human
host
howev
given
know
imprecis
natur
relationship
protein
sequenc
structur
like
method
signific
fals
neg
rate
ie
miss
mani
potenti
use
target
wo
nt
sufcient
sequenc
similar
statist
learn
method
support
vector
machin
svm
neural
network
recent
enjoy
consider
success
predict
protein
structur
may
use
identifi
target
miss
simpl
blast
search
svm
method
use
screen
human
hiv
genom
druggabl
protein
promis
degre
accuraci
similar
method
could
use
screen
tritryp
genom
algorithm
atyrodock
use
time
predict
small
molecul
potenti
flu
protein
ligandbind
pocket
first
step
ration
drug
design
process
revers
extent
use
dock
softwar
integr
molecular
dynam
simul
predict
drug
like
bind
inhibit
proteas
human
coronaviru
cytomegaloviru
human
immunodefici
viru
hiv
recent
public
describ
use
method
screen
compound
chsmbank
databas
http
chembankbroadharvardedu
protein
plasmodium
falciparum
whose
structur
determin
xray
approach
found
ks
predict
three
exist
antimalari
drug
compar
well
known
valu
predict
inhibitori
activ
rank
top
percentil
test
drug
anoth
drug
predict
multitarget
activ
ie
show
high
affin
two
protein
multitarget
drug
attract
less
like
encount
problem
develop
drug
resist
possibl
screen
tritryp
proteom
multitarget
drug
use
similar
approach
obvious
one
major
constraint
avail
lack
thereof
trypanosomatid
protein
known
structur
current
protein
structur
databas
pdb
contain
nonredund
structur
genera
leishmania
trypanosoma
howev
number
increas
rapidli
last
year
due
effort
structur
genom
pathogen
protozoa
sgpp
consortium
http
wwwsgpporg
like
increas
near
futur
recent
complet
tritryp
genom
sequenc
project
provid
unpreced
opportun
develop
novel
antitrypanosomatid
chemotherapeut
agent
identif
new
proteincod
gene
mani
share
leishmania
trypanosoma
genera
vastli
expand
potenti
drug
target
avail
investig
fact
situat
gone
rel
dearth
use
target
embarrass
rich
far
potenti
target
avail
possibl
studi
detail
chapter
describ
sever
differ
comput
approach
use
reduc
smorgasbord
gene
manag
number
highvalu
target
form
basi
detail
biolog
pharmacolog
investig
cours
target
identif
first
stage
lengthi
expens
process
drug
develop
step
target
valid
lead
identif
optim
well
preclin
pharmacolog
screen
necessari
potenti
drug
enter
clinic
trial
nevertheless
bioinformat
method
hold
great
promis
abl
identifi
target
potenti
lead
compound
case
higher
probabl
success
drug
develop
tradit
method
time
reveal
valid
promis
hope
advent
postgenom
era
trypanosomatid
biolog
herald
renaiss
discoveri
much
need
new
drug
devast
diseas
caus
parasit
